Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up

European Journal of Surgical Oncology

Volumn 37, Issue 7, 2011, Pages 563-570

  Avril, A ^a   Le Bouedec G ^b   Lorimier, G ^c   Classe, J M ^d   Tunon De Lara, C ^a   Giard, S ^e   MacGrogan, G ^a   Debled, M ^a   Mathoulin Pelissier S ^a,f,g,h   Mauriac, L ^a  

^a INSTITUT BERGONIÉ   (France)

^b CENTRE JEAN PERRIN   (France)

^c CENTRE PAUL PAPIN   (France)

^d CENTRE RENÉ GAUDUCHEAU   (France)

^e CENTRE OSCAR LAMBRET   (France)

^f INSERM   (France)

^g Centre of Clinical Investigation Clinical Epidemiology   (France)

^h UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Axillary clearance; Axillary dissection; Axillary lymph nodes; Breast cancer surgery; Early breast cancer

Indexed keywords

HORMONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; AXILLARY LYMPH NODE CLEARANCE; BREAST CANCER; BREAST SURGERY; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; FUNCTIONAL DISEASE; HISTOLOGY; HUMAN; HUMAN TISSUE; PHASE 3 CLINICAL TRIAL; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; EARLY TERMINATION OF CLINICAL TRIALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTMENOPAUSE; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TAMOXIFEN;

EID: 79959544202     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.04.008     Document Type: Article

References (29)

1. P.A. Cabanes, R.J. Salmon, J.R. Vilcoq, J.C. Durand, A. Fourquet, and C. Gautier Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie Lancet 339 1992 1245 1248
2. M. Sanghani, E.M. Balk, and B. Cady Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis Cancer 115 2009 1613 1620
3. C. Louis-Sylvestre, K. Clough, B. Asselain, J.R. Vilcoq, R.J. Salmon, and M. Overgaard Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up J Clin Oncol 22 2004 97 101 (Pubitemid 41095119)
4. R.K. Orr The impact of prophylactic axillary node dissection on breast cancer survival: a Bayesian meta-analysis Ann Surg Oncol 6 1999 109 116 (Pubitemid 29077496)
5. J. Pater, and W. Parulekar Sentinel lymph node biopsy in early breast cancer: has its time come? J Natl Cancer Inst 98 2006 568 569 (Pubitemid 43904840)
6. C.M. Rudenstam, D. Zahrieh, J.F. Forbes, D. Crivellari, S.B. Holmberg, and P. Rey Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group trial 10-93 J Clin Oncol 24 2006 337 344 (Pubitemid 46630451)
7. J.R. Benson, and G. Querci Della Rovere Axilla management consensus group. Management of the axilla in women with breast cancer Lancet Oncol 8 2007 331 348 (Pubitemid 46464531)
8. B. Cady A contemporary view of axillary dissection Ann Surg 232 2000 8 9 (Pubitemid 30456544)
9. B. Fisher, C. Redmond, E.R. Fisher, M. Bauer, N. Wolmark, and D.L. Wickerham Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation N Engl J Med 312 1985 674 681 (Pubitemid 15134703)
10. B. Fisher, C. Redmond, R. Poisson, R. Margolese, N. Wolmark, and L. Wickerham Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer N Engl J Med 320 1989 822 828 (Pubitemid 19094701)
11. G. Martelli, P. Boracchi, M. De Palo, S. Pilotti, S. Oriana, and R. Zucali A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up Ann Surg 242 2005 1 6 (Pubitemid 40917960)
12. M.J. Silverstein, E.D. Gierson, J.R. Waisman, G.M. Senofsky, W.J. Colburn, and P. Gamagami Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer 73 1994 664 667 (Pubitemid 24046609)
13. D.N. Krag, S.J. Anderson, T.B. Julian, A. Brown, S.P. Harlow, and J.P. Costantino Primary outcome results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients J Clin Oncol 28 2010 18s (abstr LBA505)
14. G. Martelli, R. Miceli, A. Costa, D. Coradini, S. Zurrida, and D. Piromalli Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study Cancer 112 2008 481 488 (Pubitemid 351186188)
15. J. Park, J.V. Fey, A.M. Naik, P.I. Borgen, K.J. Van Zee, and H.S. Cody A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram Ann Surg 245 2007 462 468 (Pubitemid 46673143)
16. S.W. Duffy, L. Tabar, G. Fagerberg, A. Gad, O. Grontoft, and M.C. South Breast screening, prognostic factors and survival - results from the Swedish two county study Br J Cancer 1991 64
17. G. Piaggio, D.R. Elbourne, D.G. Altman, S.J. Pocock, and S.J. Evans Reporting of noninferiority and equivalence randomized trials JAMA 295 2006 1152 1160
18. C.K. Axelsson, M. During, P.M. Christiansen, P.A. Wamberg, K.L. Soe, and S. Moller Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer Br J Surg 96 2009 40 46
19. H. MacPherson Pragmatic clinical trials Complement Therap Med 12 2004 136 140 (Pubitemid 39618841)
20. H. Mouridsen, A. Keshaviah, A.S. Coates, M. Rabaglio, M. Castiglione-Gertsch, and Z. Sun Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial J Clin Oncol 25 2007 5715 5722
21. R.K. Hernandez, H.T. Sorensen, L. Pedersen, J. Jacobsen, and T.L. Lash Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study Cancer 115 2009 4442 4449
22. A.E. Giuliano, K.K. Hunt, K.V. Ballman, P.D. Beitsch, and P.W. Whitworth Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA 305 2011 569 575
23. P.M. Ravdin, L.A. Siminoff, G.J. Davis, M.B. Mercer, J. Hewlett, and N. Gerson Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer J Clin Oncol 19 2001 980 991 (Pubitemid 32176272)
24. S. Samphao, J.M. Eremin, M. El-Sheemy, and O. Eremin Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach Ann Surg Oncol 15 2008 1282 1296
25. M. Greco, R. Agresti, N. Cascinelli, P. Casalini, R. Giovanazzi, and A. Maucione Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis Ann Surg 232 2000 1 7 (Pubitemid 30456543)
26. B.A. Cady Randomized trial comparing axillary dissection to no axillary dissection in elderly patients with T1N0 breast cancer: results after long-term follow-up Ann Surg 242 2005 7 9
27. A.E. Giuliano, L.M. McCall, P.D. Beitsch, P.W. Whitworth, M. Morrow, and P.W. Blumencranz ACOSOG Z0011: a randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node J Clin Oncol 28 2010 18s (abstr CRA506)
28. A.H. Madsen, K. Haugaard, J. Soerensen, S. Bokmand, E. Friis, and H. Holtveg Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group Breast 17 2008 138 147 (Pubitemid 351478254)
29. J.S. Rietman, J.H. Geertzen, H.J. Hoekstra, P. Baas, W.V. Dolsma, and J. de Vries Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer Eur J Surg Oncol 32 2006 148 152 (Pubitemid 43257114)